Pharm - HIV - General Flashcards
protease inhibitors
lopinavir rotinavir indinavir atazanavir darunavir
NRTIs
zidovudine
stavudine
didanosine
tenofovir
lamivudine
emtricitabine
abacavir
NNRTIs
nevirapine efavirenz delavirdine rilpivirine doravirine
integrase inhibitors
raltegravir
bictegravir
dolutegravir
eluitegravir
fusion inhibitors
enfuvirtide
docking inhibitors
maraviroc (blocks CCR5 on macrophage)
protease inhibitors
MOA/AE
(-navir)
MOA: inhib HIV protease, viral particles can bud off but are immature/noninfectious
AE: nausea/diarrhea HLD hypERglycemia lipodystrophy (buffalo bump)
____ are often given with a booster to inc drug levels
protease inhibitors
booster=ritonavir, cobicistat
protease inhibitors
resistance
Highly potent, resistance slow to occur
*never use as monotherapy
ritonavir AE
inhib p450 –> drug-drug interactions
protease inhibitor booster
atazanavir
indirect hyperbilirubinemia
NRTI
MOA/AE
MOA: mimic structures of nucleotides (but lack -OH), allosterically bind RT, halts chain growth
AE: mitochondrial toxicity
- peripheral neuropathy
- myopathy
- pancreatitis
- lactic acidosis
- peripheral lipotrophy (subQ loss)
which NRTI is actually a nucleotide
tenofavir
nucleotide + 1 P
Which HIV tx are also active against HBV?
Tenofavir
Emtricitabine
Lamviudine
abacvir AE
MI
HS rxn if HLAB*5701 +